Update on New and Emerging Therapies for the Treatment of Heart Failure
Update on New and Emerging Therapies for the Treatment of Heart Failure
Schedule: November 5, 2021, 1:30 pm to 2:30 pm, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Audience: Accredited for Pharmacists
Other interested health care professionals welcome
Credits: 1 Contact Hour knowledge based, 0.1CEU will be awarded under the provider, 0837-9999-21-225-L01-P
Presenter: Adam Scala, PharmD, RPh, PGY1 Acute Care Pharmacy Resident, Dartmouth-Hitchcock
Registration: Free to all attendees
Learning Objectives:
After attending this program, participants will be able to:
- Identify the differences between the 2017 ACC Heart Failure with Reduced Ejection Fraction Guidelines to the 2021 Guideline Update
- Describe the current literature on the use of different medications that have been approved or further studied since the publication of the 2017 ACC Heart failure Reduced Ejection Fraction Guidelines
- Select an appropriate treatment plan for heart failure based on a stage, functional status, and patient characteristics
Requirements for Receiving CE Credit:
- Successful completion of post-presentation questions
- Participation at live program
- Complete program evaluation form